ATE204271T1 - Verfahren zur herstellung simvastatin von lovastatin oder mevinolinsäure - Google Patents

Verfahren zur herstellung simvastatin von lovastatin oder mevinolinsäure

Info

Publication number
ATE204271T1
ATE204271T1 AT97111277T AT97111277T ATE204271T1 AT E204271 T1 ATE204271 T1 AT E204271T1 AT 97111277 T AT97111277 T AT 97111277T AT 97111277 T AT97111277 T AT 97111277T AT E204271 T1 ATE204271 T1 AT E204271T1
Authority
AT
Austria
Prior art keywords
formula
treating
iii
compound
produce
Prior art date
Application number
AT97111277T
Other languages
English (en)
Inventor
Yatendra Kumar
Rajesh Kumar Thaper
Satyananda Misra
S M Dileep Kumar
Jag Mohan Khanna
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25221004&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE204271(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Application granted granted Critical
Publication of ATE204271T1 publication Critical patent/ATE204271T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT97111277T 1997-03-13 1997-07-04 Verfahren zur herstellung simvastatin von lovastatin oder mevinolinsäure ATE204271T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/816,573 US5763646A (en) 1997-03-13 1997-03-13 Process for manufacturing simvastatin from lovastatin or mevinolinic acid

Publications (1)

Publication Number Publication Date
ATE204271T1 true ATE204271T1 (de) 2001-09-15

Family

ID=25221004

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97111277T ATE204271T1 (de) 1997-03-13 1997-07-04 Verfahren zur herstellung simvastatin von lovastatin oder mevinolinsäure

Country Status (7)

Country Link
US (1) US5763646A (de)
EP (1) EP0864569B1 (de)
AT (1) ATE204271T1 (de)
AU (1) AU693401B1 (de)
DE (1) DE69706135T2 (de)
ES (1) ES2162165T3 (de)
ZA (1) ZA974023B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0940395A1 (de) * 1998-03-05 1999-09-08 Synthon B.V. Verfahren zur Erzeugung von Simvatarin in und/oder deren Derivate
NO991045L (no) * 1998-03-05 1999-09-06 Synthon Bv FremgangsmÕte ved fremstilling av simvastatin og/eller dets derivater
US20030078211A1 (en) * 1998-06-24 2003-04-24 Merck & Co., Inc. Compositions and methods for inhibiting bone resorption
US6432931B1 (en) 1998-06-24 2002-08-13 Merck & Co., Inc. Compositions and methods for inhibiting bone resorption
JP2002518448A (ja) * 1998-06-24 2002-06-25 メルク エンド カムパニー インコーポレーテッド 高血中コレステロールを治療する組成物および方法
SI20070A (sl) 1998-09-18 2000-04-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Nove soli inhibitorjev HMG-CoA reduktaze
CZ299522B6 (cs) * 1998-12-10 2008-08-27 Kaneka Corporation Zpusob výroby diolu obsahujícího laktonovou skupinu
CO5140104A1 (es) * 1999-02-16 2002-03-22 Novartis Ag Derivados de mevinolina y preparacion farmaceuticas que los contienen
WO2001034590A1 (en) * 1999-11-11 2001-05-17 Biocon India Limited Process for manufacturing simvastatin and the novel intermediates
US6573385B1 (en) 1999-11-11 2003-06-03 Biocon India Limited Process for manufacturing simvastatin and novel intermediates thereof
IN192861B (de) * 2000-06-30 2004-05-22 Ranbaxy Lab Ltd
US6472542B1 (en) * 2001-11-29 2002-10-29 Fermic S.A. De C.V. Method for alkylating the alpha carbon of the 2-methylbutyrate secondary chain of lovastatin
SI21187A (sl) 2002-03-26 2003-10-31 Krka, Tovarna Zdravil D.D., Novo Mesto Postopek za pripravo 4-oksitetrahidropiran-2-onov
US6603022B1 (en) 2002-05-10 2003-08-05 Biocon India Limited Process for manufacturing Simvastatin and novel intermediates thereof
US20080293750A1 (en) * 2002-10-17 2008-11-27 Anna Helgadottir Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment
US20060019269A1 (en) * 2002-10-17 2006-01-26 Decode Genetics, Inc. Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment
EP3028739A1 (de) * 2003-10-31 2016-06-08 Sunshine Heart Company Pty Ltd Synchronisationssteuerungssystem
US7205415B2 (en) * 2004-01-02 2007-04-17 Hetero Drugs, Ltd. Process for the preparation of simvastatin
US8158362B2 (en) * 2005-03-30 2012-04-17 Decode Genetics Ehf. Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
US20100216863A1 (en) * 2004-01-30 2010-08-26 Decode Genetics Ehf. Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment
EP1786765B1 (de) * 2004-09-08 2009-09-02 Jubilant Organosys Limited Verbessertes verfahren zur lactonisierung bei der herstellung von statinen
CN1754870A (zh) * 2004-09-30 2006-04-05 淮北市辉克药业有限公司 辛伐他汀的制备方法
WO2006072963A1 (en) * 2005-01-10 2006-07-13 Concord Biotech Limited Process for preparing simvastatin from lovastatin amine salts in three steps
WO2007020079A2 (en) * 2005-08-17 2007-02-22 Synthon B.V. Orally disintegratable simvastatin tablets
US20070129437A1 (en) * 2005-12-06 2007-06-07 Ferenc Korodi Process for preparing simvastatin and intermediates thereof
ES2343049B1 (es) 2008-10-15 2011-06-10 Neuron Biopharma, S.A. Biosintesis de derivados de monacolina j.
ES2614804T3 (es) 2009-09-30 2017-06-02 Codexis, Inc. Acilación mejorada mediada por LovD aciltransferasa
SG10201504099WA (en) 2009-10-08 2015-06-29 Univ California LovD MUTANTS EXHIBITING IMPROVED PROPERTIES TOWARDS SIMVASTATIN SYNTHESIS
CN104744416A (zh) * 2015-03-25 2015-07-01 河南师范大学 一种辛伐他汀的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (de) * 1974-06-07 1981-03-18
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
US4293496A (en) * 1980-02-04 1981-10-06 Merck & Co., Inc. 6(R)-[2-(8-Hydroxy-2,6-dimethylpolyhydronaphthyl-1)-ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones
US4450171A (en) * 1980-08-05 1984-05-22 Merck & Co., Inc. Antihypercholesterolemic compounds
US4582915A (en) * 1983-10-11 1986-04-15 Merck & Co., Inc. Process for C-methylation of 2-methylbutyrates
US4584389A (en) * 1983-10-11 1986-04-22 Merck & Co., Inc. Processes for preparing 6(R)-[2-[8(S)(2,2-dimethylbutyryloxy)-2(S),6(S)-dimethyl-1,2,3,4,4a(S),5,6,7,8,8a(S)-decahydronaphthyl-1(S)]ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one
EP0137445B1 (de) * 1983-10-11 1990-01-03 Merck & Co. Inc. Verfahren zur C-Methylierung von 2-Methylbutyraten
US4611081A (en) * 1985-07-05 1986-09-09 Merck & Co., Inc. Process for the preparation of HMG-CoA reductase inhibitors intermediates
US4820850A (en) * 1987-07-10 1989-04-11 Merck & Co., Inc. Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof
US5177104A (en) * 1990-04-03 1993-01-05 E. R. Squibb & Sons, Inc. 6-α-hydroxy derivatives of mevinic acids
US5223415A (en) * 1990-10-15 1993-06-29 Merck & Co., Inc. Biosynthetic production of 7-[1',2',6',7',8',8a'(R)-hexahydro-2'(S),6'(R)-dimethyl-8'(S)-hydroxy-1'(S)-naphthyl]-3(R),5(R)-dihydroxyheptanoic acid (triol acid)
US5159104A (en) * 1991-05-01 1992-10-27 Merck & Co., Inc. Process to simvastatin ester
US5393893A (en) * 1993-11-08 1995-02-28 Apotex, Inc. Process for producing simvastatin and analogs thereof

Also Published As

Publication number Publication date
ZA974023B (en) 1997-12-10
ES2162165T3 (es) 2001-12-16
AU693401B1 (en) 1998-06-25
US5763646A (en) 1998-06-09
EP0864569A1 (de) 1998-09-16
DE69706135D1 (de) 2001-09-20
EP0864569B1 (de) 2001-08-16
DE69706135T2 (de) 2002-05-02

Similar Documents

Publication Publication Date Title
ATE204271T1 (de) Verfahren zur herstellung simvastatin von lovastatin oder mevinolinsäure
BR9811533A (pt) Produção de compostos avermectina
EA200200481A1 (ru) Способ получения производных 4-трифторметилсульфинилпиразола
ATE174589T1 (de) Verfahren zur herstellung von piperidinderivaten
EA200100229A1 (ru) Пептидные ингибиторы вируса гепатита с
ATE282020T1 (de) Verfahren zur herstellung von 2-aminomalonsäure- derivaten
CO5180605A1 (es) Compuestos de indol
EA200400129A1 (ru) Способ получения периндоприла, его аналогов и солей с использованием 2,5-диоксооксазолидиновых промежуточных соединений
ATE216231T1 (de) Verfahren zur herstellung von avermectin/zein- zusammensetzungen
DE60039601D1 (de) Antisense gegen c-myc zur behandlung von polyzystischer nierenkrankheit
ATE183989T1 (de) Verfahren zur herstellung von 2-(substituierten benzoyl)-1,3 cyclohexanedionen
ATE219487T1 (de) Verfahren zur herstellung von lamotrigine
ES2182317T3 (es) Produccion de compuestos de avermectina.
ATE384067T1 (de) Verfahren zur herstellung von 3-cephemderivaten
DE69901792D1 (de) Verfahren zur herstellung von 2-acetylthio-3-phenyl-propionsäure und deren salzen
DE69809888D1 (de) Verfahren zur Herstellung von alpha-Aminoketonen
ATE258605T1 (de) Verfahren zur herstellung von (1r,4s)-2- azabicyclo 2.2.1 hept-5-en-3-on-derivaten
BR0210512A (pt) Processo de decomposição papa o ácido (r)-(-)-2-hidroxi-2-(2-clorofenil) acético
EA199900735A1 (ru) Соединения и способ получения замещенных 4-фенил-4-цианоциклогексановых кислот
ATE120179T1 (de) Verfahren zum herstellen von alpha-fluorierten acrylaten.
ATE146183T1 (de) Verfahren zur herstellung von ribonukleotid- reduktasehemmern
ATE186046T1 (de) Verfahren zur herstellung von hydroxylamin-ethern sowie deren salzen und zwischenprodukte hierfür
MX9701332A (es) Metodos para curar y reparar fracturas oseas.
ATE301637T1 (de) Verfahren zur herstellung von n-geschützten azetidin-2-carbonsäuren
GB2333293A (en) Process for the preparation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee
RZN Patent revoked